You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. DNA Pro-Drug Technology in Localized Wound Healing and Tissue Regeneration

    SBC: International Medicine and Biomedical Research            Topic: NIAMS

    DESCRIPTION (provided by applicant): Advancement in wound management or tissue repair has been limited by the complexities, costs and limited efficacy of purified recombinant growth factors. Further, the combination of these recombinant proteins for moresophisticated approaches is complicated by the need for separate biologics. Optimally, we can move to a single biologic DNA pro-drug that provide ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  2. Microvascular Functional Imaging System

    SBC: VisionQuest Biomedical Inc            Topic: NIDDK

    DESCRIPTION (provided by applicant): VisionQuest Biomedical and the University of New Mexico (UNM) Health Science Center have formed a team to implement and demonstrate a thermal-optical imaging system for detecting and quantifying neuronal and microvascular dysfunction associated with peripheral neuropathy. This team will develop and test the Microvascular1Functional Imaging System (MFIS), ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  3. High Efficiency Anti-scatter Grid System for Fluoroscopy

    SBC: X-RAY IMAGING INNOVATIONS            Topic: NIBIB

    DESCRIPTION (provided by applicant): Antiscatter grids currently employed on fluoroscopic systems are limited in their capability to control scatter. As a result, fluoroscopic radiation levels are higher for the average patient than they would be with a more efficient grid system, and higher still for large patients. Poor image quality often increases the beam-on time required to successfully perf ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  4. Gaze-guided Localized Image Magnification Peripheral Sight Enabler for Low Vision

    SBC: SMART ENGINEERING            Topic: NEI

    DESCRIPTION (provided by applicant): Central vision field loss (CFL) is caused by inherited and acquired diseases that irreversibly damage the fovea while leaving the peripheral retina relatively intact. CFL results in 1,700,000 legal blindness and lowvision (LV) cases in the US. LV rehabilitation is the means of restoring functional abilities modified by CFL so that the patient's quality ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  5. Developing functional membrane protein arrays for highly efficient drug screening

    SBC: 3D Glass Solutions, Inc.            Topic: NIGMS

    DESCRIPTION (provided by applicant): Membrane proteins are an essential component of intercellular signaling pathways. The overwhelming majority of small molecule drugs, either directly or indirectly, target membrane proteins. Arrays of membrane proteins would be important tools in drug screening and academic research laboratories in studies of interactions between proteins and lipids, proteins an ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  6. Ultra-Compact MRI: A new cost-effective tool optimized for developmental biology

    SBC: ABQMR, INC.            Topic: NCRR

    DESCRIPTION (provided by applicant): Research using Xenopus (frog) embryos, a model system of major importance in many areas of biomedicine, is hampered in a fundamental way by their opacity. No device for non-destructively imaging the interiors of these specimens is generally available. The long-term goal at ABQMR, Inc. is to utilize unique capabilities in the field of miniaturized NMR and MRI in ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  7. Development of Wraparound Team Monitoring System (Wrap-TMS)

    SBC: ACCOUNTABILITY SOLUTIONS, INC.            Topic: NIMH

    DESCRIPTION (provided by applicant): The wraparound service model (WSM) is an individualized care planning and management process for children and youth with serious emotional and behavioral disorders (SEBD) that is implemented in nearly 1000 sites in theUnited States. The purpose of this Phase I Small Business Technology Transfer (STTR) proposal is to develop and pilot test a web-based monitoring ...

    STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  8. Selective Decorporation Agents for NIAID

    SBC: Icagen, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): This Phase II project continues the successful Phase I discovery of novel decorporation agents that are selective for radioactive strontium (Sr). This project consists of the necessary steps for submission of an Emergency Use Authorization (EUA) or Investigational New Drug (IND) application to the US FDA. A goal is to have orally- administered, GI-chelation for ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  9. CF Corrector Ligands Discovered on CF Human Airway Cells

    SBC: DISCOVERYBIOMED, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): DiscoveryBioMed, Inc. (DBM) achieved Phase 1 SBIR milestones and seeks to continue a mature program that has progressed to the hit-to-lead drug validation, prioritization and progression stage. DBM s major over-archinggoal for this program is to identify novel clinical candidate CFTR Corrector Ligands (CFCLs) for the treatment of CF through the completion of a ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Nanotechnology Enabled Temporomandibular Joint(TMJ)Prosthesis

    SBC: VISTA ENGINEERING, INC.            Topic: NIDCR

    DESCRIPTION (provided by applicant): Temporomandibular Disorders (TMD) represent a collection of medical and dental conditions affecting the temporomandibular joint (TMJ) and/or the muscles of mastication, as well as contiguous tissue structures. For somepatients with severe TMJ degeneration, a prosthetic replacement may be required. However, long-term success and functioning of current implant d ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government